Check out our new  press release hub , powered by Business Wire. It's a one stop shop for industry announcements to help you stay on top of the latest technology and investment trends. Get the scoop  here .
BOCA RATON, Fla.–(BUSINESS WIRE)–November 21, 2013–
Zero       Gravity Solutions, Inc. (ZGSI or “the Company”), (Pink Sheets:       ZGSI), announced today the appointment of former Congressman Robert S.       Walker as Legislative and Regulatory Advisor. Congressman Walker has       been a leading voice in Congress as to the funding and value of the       United States Space Program and the International Space Station in       particular as Chairman of the House Committee on Science and Technology.       Mr. Walker has served on the President’s Commission on Implementation of       United States Space Exploration Policy and on the President’s Commission       on the Future of the United States Aerospace Industry.
Harvey Kaye, Chairman of the Company, stated, “Bob has been on the       forefront in setting policy for the future direction of our nation’s       space program. He is exceptionally qualified to assist our company with       monitoring the political dynamics which relate to ZGSI’s business as       well as develop and nurture key relationships within the legislative and       regulatory communities.”
Richard Godwin, Chief Executive Officer and President of ZGSI, stated,       “I have been involved for more than 20 years with various aspects of the       potential to commercialize Low Earth Orbit and the ISS, including recent       work with Elon Musk and SpaceX. I have had the opportunity to see       first-hand Bob’s unwavering commitment to the nation’s human space       program and also the intellectual firepower he brings to our company.”
Mr. Walker, ZGSI’s newly appointed Legislative and Regulatory Advisor,       stated, “I am delighted to become a part of the ZGSI team. When the       International Space Station was created, our dream was to produce world       class science that would lead to remarkable new products for all of       humankind. ZGSI is in the forefront of making that dream a reality, and       I hope my experience in government policy will help grow a company that       is focused on the future.”
About Zero Gravity Solutions, Inc.
Zero       Gravity Solutions, Inc. is a zero gravity biotechnology company       whose mission is to improve life on earth by using technology designed       for and derived from space and through utilization of the       unique long-term microgravity environment platform of the International       Space Station (ISS). The Company’s initial projects will be directed to       providing solutions to critical world food crops challenges. The Company       owns proprietary technology for its first commercial product, BAM-FX™       that can boost the nutritional value and enhance the immune system of       food crops without the use of Genetic Modification. Further, the Company       is focused on industrializing and commercializing scientific       breakthroughs in the area of patentable stem cell technologies through       developing advances in plant, animal and human biology based on       intellectual property designed for and derived from multiple experiments       on the ISS. The Company owns intellectual property that is designed to       develop and produce, in a microgravity environment and without Genetic       Modification techniques, large volumes of novel stem cells with unique       and beneficial characteristics, which can be patented for commercial       sale to third parties in the agricultural and human regenerative medical       markets. ZGSI is headquartered in Boca Raton, Florida with offices       and/or operations in Naperville, Illinois and Stevensville, Maryland.       Information on the Company can be viewed on www.zerogsi.com .
This press release may contain certain forward-looking statements within       the meaning of Section 27A of the Securities Act of 1933, as amended,       and Section 21E of the Securities Exchange Act of 1934, as amended.       Investors are cautioned that such forward-looking statements involve       risks and uncertainties, including without limitation, acceptance of the       Company’s products, increased levels of competition for the Company, new       products and technological changes, the Company’s dependence on       third-party suppliers, and other risks detailed from time to time in the       Company’s periodic reports filed with the Securities and Exchange       Commission.
